Second Systemic Sclerosis World Congress a Success PDF Print E-mail
Tuesday, 13 March 2012 14:09
Great success for the second Systemic Sclerosis World Congress that was held in February at the Palacio de Congresos de Madrid.

After the positive experience of 2010 in Florence, AIM Group International organised the second edition the congress, on behalf of World Scleroderma Foundation, founded by Alexander Klee, grandson of the great painter Paul Klee, who also a suffers from scleroderma, a so-called "rare" disease with very painful and debilitating effects.

To approach the social aspects of the disease, the Congress opened to the patients’ associations (FESCA - Scleroderma Federation of European Associations) and organized a parallel conference with hundreds of patients who had the opportunity to debate on clinical cases, experiences and opinions with experts and prominent international physicians.

With a qualified program consisting of seventy seven lectures, around sixty oral presentations and three hundred posters, the Congress attracted over 1,300 delegates from around the world: in fact, in addition to a prevalent presence from European countries, some hundred American, Asian and African participants contributed to reinforcing the international nature of the meeting.

At the end of the World Congress, the Scleroderma Foundation, chaired by Prof. Marco Matucci Cerinic, AIM Group International were appointed for the organisation of the next Congress, to be held in Paris in 2014.

Source: Agency & Association (2012), "The World Scleroderma Foundation meets in Madrid for the “Systemic Sclerosis World Congress” organised by AIM Group International"; ITCM

 
More articles :

» HSCT Benefits In Early Diffuse Cutaneous Systemic Sclerosis

Initial results from an international, investigator-initiated, open label phase 3 trial, presented at EULAR 2012, indicate that haematopoietic stem cell transplantation (HSCT) results in better long-term survival than conventional treatment for...

» Clinical Correlates Of Sleep Problems In Systemic Sclerosis: The Prominent Role Of Pain

Objective. Problems with sleep are common in patients with SSc and impact daily function. Little research, however, has examined factors associated with sleep disruption in SSc. Therefore, the objective of this study was to investigate...

» A Simple Blood Test Could Hold The Clue...

In a recent press release, the reported that a simple blood test could hold the clue and may even save lives. is a common condition, especially in teenagers, affecting approximately 10 million people in the UK. It can vary from being mild to very...

» Caution Needed When Using ACE Inhibitors in Scleroderma

Exposure to angiotensin-converting enzyme inhibitors prior to the onset of renal crisis in patients with increases the risk of death, according to 1-year findings from the prospective observational International Scleroderma Renal Crisis Survey.The...

» Interleukin-6: A New Therapeutic Target in Scleroderma

Interleukin-6 (IL-6) is a classic pro-inflammatory cytokine critical in mounting an effective immune response. It is secreted by a wide array of cell types; however, its effector cells are more restricted, owing to the fact that very few cells,...

» Special Surgery Scientists To Share Advances in Lupus and Related Conditions

Hospital for Special Surgery physicians who focus on lupus, scleroderma and related conditions are traveling from New York City to Atlanta this week to share their recent findings at the 74th Annual Scientific Meeting of the American College of...